Real-world Impact of 3 and 4.5 mg Doses of Dulaglutide on Weight and Hemoglobin A1c in Patients With Type 2 Diabetes Mellitus
CONCLUSION AND RELEVANCE: Titration from dulaglutide 1.5 to 3 mg resulted in significant reductions in weight and HbA1c after 24 weeks. Additional, statistically significant, reductions in weight and HbA1c were seen when patients were further titrated to dulaglutide 4.5 mg weekly.PMID:37743669 | DOI:10.1177/10600280231199852
Source: The Annals of Pharmacotherapy - Category: Drugs & Pharmacology Authors: Amy Duong Samantha Heacock Sarah Amering Lillian Brennan Jineane Venci Nicole M Acquisto Source Type: research
More News: Diabetes | Diabetes Mellitus | Diabetes Type 2 | Drugs & Pharmacology | Endocrinology | Primary Care | Statistics | Study